# Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/health-care-resource-utilization-and-direct-costs-incurred-over-24-months-after/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Oralee J. Varnado,Michelle Vu,Erin Buysman,Gilwan Kim,Gayle Allenback,Margaret Hoyt,Helen Trenz,Feng Cao,Lars Viktrup |
| Citations | 1 |
| DOI | 10.18553/jmcp.2024.30.8.792 |
| Fields | Medicine,Social Sciences |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC11293767/pdf/jmcp.2024.30.8.792.pdf |
| OpenAlex ID | https://openalex.org/W4401212656 |
| PMID | 39088336 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Gilwan Kim](https://scholariq.org/researchers/gilwan-kim/)
- [Michelle Vu](https://scholariq.org/researchers/michelle-vu/)
- [Erin Buysman](https://scholariq.org/researchers/erin-buysman/)
- [Feng Cao](https://scholariq.org/researchers/feng-cao/)
- [Lars Viktrup](https://scholariq.org/researchers/lars-viktrup/)

## Paper funders

- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)

## Paper journal

- [Journal of Managed Care & Specialty Pharmacy](https://scholariq.org/journals/journal-of-managed-care-and-specialty-pharmacy/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Vaccine Coverage and Hesitancy](https://scholariq.org/topics/vaccine-coverage-and-hesitancy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.